Anti-Cytokeratin 7, Keratin K7 antibody (Clone: RCK105)

Referência NB-22-73165-100

Tamanho : 100ug

Solicitar mais informações

Contactar o distribuidor local :


Telefone : +1 850 650 7790

  • Anti-Cytokeratin 7, Keratin K7 antibody [RCK105]

General Info

Host: Mouse
Applications: FC/ICC/IHC-F/WB
Reactivity: Human/Mouse/Rat/Zebrafish/Dog/Caprine/Feline/Hamster
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Cytokeratin 7, Keratin K7 is suitable for use in Flow Cytometry, Immunocytochemistry, Immunohistochemistry and Western Blot research applications.
Clonality: Monoclonal
Clone ID: RCK105
Conjugation: Unconjugated
Isotype: IgG1
Formulation: PBS with 0.09% sodium azide
Concentration: 1 mg/mL
Storage Instruction: Store at 2-8°C upon receipt.

Information

Immunogen: cytokeratins from the human bladder carcinoma cell line T24

Description

Background Cytokeratins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in Human epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 – 7.8. The individual Human Cytokeratins are numbered 1 to 20. The various epithelia in the Human body usually express Cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of maturation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used in the distinction of different types of epithelial malignancies. The Cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays. RCK105 reacts exclusively with Cytokeratin 7 which is present in a subgroup of glandular epithelia and their tumors, as well as transitional epithelium and transitional carcinoma.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance